Skip to main content

Want a detailed portfolio tracker?

Translational Development Acquisition Corp. Ordinary Shares (TDAC) Income Statement (2022 - 2026)

Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for Translational Development Acquisition Corp. Ordinary Shares (TDAC).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2022
Revenue and COGS
Total Revenue
--550.00K140K
(-26.32%)
190K-------
Cost Of Revenue
--530.00K200K
(+25.00%)
160K-------
Costof Goods And Services Sold
--530.00K200K
(+25.00%)
160K-------
Gross Profit
--20.00K
(-71.43%)
-70.00K30K-------
Operating Expenses
Selling General And Administrative
280K
(+75.00%)
160K
(-23.81%)
210K
(-4.55%)
220K
(+69.23%)
130K
(+116.67%)
60K-----
Operating Expenses
280K
(+75.00%)
160K
(-23.81%)
210K
(-4.55%)
220K
(+69.23%)
130K
(+116.67%)
60K-----
Operating Income
Operating Income
-280.00K
(+75.00%)
-160.00K
(-23.81%)
-210.00K
(-4.55%)
-220.00K
(+69.23%)
-130.00K
(+116.67%)
-60.00K-----
Ebit
----220.00K
(+69.23%)
-130.00K
(+116.67%)
-60.00K-----
EBITDA
-280.00K
(+75.00%)
-160.00K
(-23.81%)
-210.00K
(-4.55%)
-220.00K
(+57.14%)
-140.00K
(+133.33%)
-60.00K-----
Other Income / Expenses
Interest Income
--1.87M--------
Interest Expense
-60K-60K-------
Net Interest Income
--1.87M--------
Net Income
Income Before Tax
1.33M
(-16.88%)
1.60M
(-3.61%)
1.66M
(+2.47%)
1.62M-10.00K
(-83.33%)
-60.00K-----
Net Income From Continuing Operations
1.33M
(-16.88%)
1.60M
(-3.61%)
1.66M
(+2.47%)
1.62M-10.00K
(-83.33%)
-60.00K-----
Net Income
1.33M
(-16.88%)
1.60M
(-3.61%)
1.66M
(+2.47%)
1.62M-10.00K
(-83.33%)
-60.00K-----